We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Continuous monitoring of SARS-CoV-2 seroprevalence in children using residual blood samples from routine clinical chemistry.
- Authors
Wachter, Felix; Regensburger, Adrian P.; Antonia Sophia Peter; Knieling, Ferdinand; Wagner, Alexandra L.; Simon, David; Hoerning, André; Woelfle, Joachim; Überla, Klaus; Neubert, Antje; Rauh, Manfred
- Abstract
Graph: Figure 3: Quantitative and qualitative anti-S and anti-N analyses. anti-S=SARS-Cov-2 spike protein total antibodies.(A) SARS-Cov-2 nucleocapsid antibody response was correlated with spike protein antibody levels of all reactive samples. Keywords: COVID-19; pediatrics; prevalence; SARS-CoV-2 EN COVID-19 pediatrics prevalence SARS-CoV-2 941 951 11 05/12/22 20220501 NES 220501 Introduction Almost two years after the emerge of the novel Severe Acute Respiratory Syndrome Corona Virus (SARS-CoV-2) in 2019, the coronavirus disease 2019 (COVID-19) pandemic is still challenging people and health care systems around the world. Samples with spike antibodies above 1000 U/mL and no nucleocapsid antibodies (<0.12S/Co) were excluded from further analyses as we assumed that these patients had been vaccinated as natively-infected individuals developed a lower and more heterogeneous antibody response to SARS-CoV-2 [[14]].
- Subjects
COVID-19; VIRAL antibodies; SARS-CoV-2; CLINICAL chemistry; SEROPREVALENCE; MEDICAL personnel; BLOOD sampling
- Publication
Clinical Chemistry & Laboratory Medicine, 2022, Vol 60, Issue 6, p941
- ISSN
1434-6621
- Publication type
Article
- DOI
10.1515/cclm-2022-0037